Compile Data Set for Download or QSAR
Report error Found 269 Enz. Inhib. hit(s) with all data for entry = 12622
Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715404(US20250026765, Compound I-004)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715406(US20250026765, Compound I-007)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715408(US20250026765, Compound I-009)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715409(US20250026765, Compound I-010)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715410(US20250026765, Compound I-012)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715412(US20250026765, Compound I-014)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715413(US20250026765, Compound I-015)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715414(US20250026765, Compound I-016)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715415(US20250026765, Compound I-017)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715417(US20250026765, Compound I-019)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715419(US20250026765, Compound I-021)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715420(US20250026765, Compound I-022)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715422(US20250026765, Compound I-024)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715424(US20250026765, Compound I-026)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715425(US20250026765, Compound I-028)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715426(US20250026765, Compound I-029)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715427(US20250026765, Compound I-030)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715430(US20250026765, Compound I-034)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715431(US20250026765, Compound I-035)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715432(US20250026765, Compound I-036)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715433(US20250026765, Compound I-037)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715437(US20250026765, Compound I-041)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715440(US20250026765, Compound I-044)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715443(US20250026765, Compound I-047)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715444(US20250026765, Compound I-048)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715445(US20250026765, Compound I-050)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715448(US20250026765, Compound I-053)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715449(US20250026765, Compound I-054)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715450(US20250026765, Compound I-055)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715454(US20250026765, Compound I-060)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715456(US20250026765, Compound I-062)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715457(US20250026765, Compound I-063)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715458(US20250026765, Compound I-064)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715459(US20250026765, Compound I-065)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715460(US20250026765, Compound I-066)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715384(US20250026765, Compound I-067)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715461(US20250026765, Compound I-068)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715463(US20250026765, Compound I-070)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715464(US20250026765, Compound I-071)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715465(US20250026765, Compound I-072)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715468(US20250026765, Compound I-075)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715470(US20250026765, Compound I-077)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715471(US20250026765, Compound I-078)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715472(US20250026765, Compound I-079)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715385(US20250026765, Compound I-080)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715473(US20250026765, Compound I-081)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715474(US20250026765, Compound I-082)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715475(US20250026765, Compound I-083)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715476(US20250026765, Compound I-084)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715477(US20250026765, Compound I-085)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 269 total ) | Next | Last >>
Jump to: